Ovation Science Inc. (OVATF) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ovation Science Inc. (OVATF) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Die Aktie erzielt 61/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 16. März 2026Ovation Science Inc. (OVATF) Gesundheitswesen & Pipeline-Uebersicht
Ovation Science Inc. focuses on developing and marketing cannabis and hemp-based topical products using its patented Invisicare drug delivery technology. With operations in Canada, the United States, and Mexico, the company targets the health and wellness market through its Ovation and BASKiN brands, differentiating itself through innovative delivery systems.
Investmentthese
Ovation Science Inc. presents a focused investment opportunity within the cannabis and hemp-based topical product market. The company's patented Invisicare technology provides a competitive edge in delivering cannabinoid-infused solutions. Key value drivers include expanding market penetration in Canada, the United States, and Mexico, along with the potential for new product development and licensing agreements. A gross margin of 81.5% indicates strong pricing power. However, the company's negative profit margin of -651.1% and limited market capitalization pose significant risks. Successful execution of its growth strategies and achieving profitability are critical for long-term value creation. Upcoming catalysts include potential regulatory changes in the cannabis industry and expansion into new geographic markets.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Patented Invisicare technology offers a unique drug delivery system for topical cannabis and hemp products.
- Gross margin of 81.5% demonstrates strong potential for profitability if sales volume increases.
- Operations in Canada, the United States, and Mexico provide access to key cannabis markets.
- Diverse product portfolio includes health and wellness, skincare, and sanitization products.
- Market Cap of $0.00B indicates the company is a microcap stock with high growth potential but also high risk.
Wettbewerber & Vergleichsunternehmen
Staerken
- Patented Invisicare drug delivery technology
- Established brands in key markets
- Diverse product portfolio
- Experienced management team
Schwaechen
- Negative profit margin
- Limited market capitalization
- Dependence on regulatory approvals
- Intense competition
Katalysatoren
- Upcoming: Potential regulatory changes in the cannabis industry could expand market access.
- Ongoing: Expansion into new geographic markets will drive revenue growth.
- Ongoing: Strategic partnerships and licensing agreements can increase market reach.
- Upcoming: New product development and launches will enhance product portfolio.
- Ongoing: Increased brand awareness and marketing efforts will drive sales.
Risiken
- Potential: Changing regulatory landscape could negatively impact operations.
- Ongoing: Increased competition in the cannabis market could erode market share.
- Potential: Product liability risks associated with cannabis products.
- Potential: Economic downturn could reduce consumer spending on discretionary items.
- Ongoing: Dependence on regulatory approvals for new products and markets.
Wachstumschancen
- Expansion into New Therapeutic Areas: Ovation Science can leverage its Invisicare technology to develop topical products targeting specific therapeutic areas such as pain management, dermatology, and wound healing. The global market for topical pain relief products is projected to reach $15.7 billion by 2027, presenting a significant opportunity for Ovation Science to expand its product offerings and capture market share. Timeline: 2-3 years.
- Geographic Expansion: The company can further expand its presence in existing markets and enter new geographic regions where cannabis and hemp products are legal. The European cannabis market is projected to reach €3.2 billion by 2025, offering a substantial growth opportunity for Ovation Science to establish a foothold in this emerging market. Timeline: Ongoing.
- Strategic Partnerships and Licensing Agreements: Ovation Science can pursue strategic partnerships with established pharmaceutical companies, retailers, and distributors to expand its market reach and access new customer segments. Licensing its Invisicare technology to other companies can also generate revenue and increase brand awareness. Timeline: Ongoing.
- New Product Development: The company can invest in research and development to create new and innovative cannabis and hemp-based products that address unmet needs in the market. This includes exploring new delivery methods, formulations, and ingredients to enhance product efficacy and appeal. Timeline: 1-2 years.
- Increased Brand Awareness and Marketing Efforts: Ovation Science can invest in marketing and advertising campaigns to increase brand awareness and drive sales of its products. This includes leveraging social media, influencer marketing, and public relations to reach target audiences and promote the benefits of its products. Timeline: Ongoing.
Chancen
- Expansion into new therapeutic areas
- Geographic expansion into new markets
- Strategic partnerships and licensing agreements
- New product development
Risiken
- Changing regulatory landscape
- Increased competition
- Product liability risks
- Economic downturn
Wettbewerbsvorteile
- Patented Invisicare drug delivery technology provides a competitive advantage.
- Established brands and distribution channels in key markets.
- Focus on innovation and product development.
- Expertise in cannabis and hemp product formulation and manufacturing.
Ueber OVATF
Ovation Science Inc., established in 2017 and headquartered in Vancouver, Canada, specializes in the creation and distribution of cannabis and hemp-based products. The company's core technology, Invisicare, is a patented drug delivery system designed for topical and transdermal applications. This technology is central to the development of skincare and wellness products infused with hemp seed oil and cannabis. Ovation Science markets its products under several brands, including Ovation and BASKiN, which offer a range of topical solutions. Additionally, the company provides cannabidiol-infused health and wellness products under the Invibe MD brand, skincare solutions under the ARLO CBD name, and hand sanitizers under the DermSafe brand. Ovation Science operates in Canada, the United States, and Mexico, holding sublicenses for cannabis-based products and the Lighthouse brand for licensed dispensaries in the United States. The company aims to leverage its innovative technology and diverse product portfolio to capture a significant share of the growing cannabis and hemp market.
Was das Unternehmen tut
- Develops and commercializes topical cannabis and hemp products.
- Utilizes patented Invisicare drug delivery technology.
- Offers cannabidiol-infused health and wellness solutions.
- Provides skincare solutions under the ARLO CBD brand.
- Markets hand sanitizers under the DermSafe name.
- Holds sublicenses for cannabis-based products.
- Operates in Canada, the United States, and Mexico.
Geschaeftsmodell
- Develops and manufactures cannabis and hemp-based topical products.
- Markets and sells products through its own brands and distribution channels.
- Generates revenue through product sales and licensing agreements.
- Focuses on innovation and product development to maintain a competitive edge.
Branchenkontext
Ovation Science Inc. operates within the rapidly expanding cannabis and hemp industry, which is experiencing significant growth due to increasing legalization and acceptance of cannabis-based products for medicinal and recreational use. The market is characterized by intense competition, with numerous companies vying for market share in various segments, including topicals, edibles, and beverages. Ovation Science's focus on topical applications and its patented Invisicare technology position it to capitalize on the growing demand for innovative and effective cannabis-infused products. The company faces competition from both established pharmaceutical companies and emerging cannabis startups.
Wichtige Kunden
- Consumers seeking topical cannabis and hemp products for health and wellness.
- Patients seeking relief from pain, inflammation, and other conditions.
- Retailers and dispensaries that sell cannabis and hemp products.
- Companies that license Ovation Science's Invisicare technology.
Finanzdaten
Chart & Info
Ovation Science Inc. (OVATF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer OVATF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer OVATF.
Kursziele
Wall-Street-Kurszielanalyse fuer OVATF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von OVATF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Terry H. Howlett
CEO
Terry H. Howlett serves as the CEO of Ovation Science Inc. His background includes extensive experience in the pharmaceutical and healthcare industries. Prior to joining Ovation Science, he held leadership positions at various companies, focusing on product development, marketing, and sales. His expertise spans across multiple therapeutic areas, including dermatology and pain management. Howlett's experience in bringing innovative products to market is expected to drive Ovation Science's growth strategy.
Erfolgsbilanz: Under Terry Howlett's leadership, Ovation Science has focused on expanding its product portfolio and market reach. Key milestones include the development and launch of new cannabis and hemp-based topical products, as well as the establishment of strategic partnerships to expand distribution channels. Howlett's strategic decisions have been instrumental in positioning Ovation Science as a leader in the cannabis topical market.
OVATF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ovation Science Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases investment risk.
- Low trading volume and wide bid-ask spreads can lead to price volatility.
- Fewer regulatory requirements compared to major exchanges.
- Potential for fraud or manipulation.
- Higher risk of delisting or going out of business.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Patented Invisicare technology.
- Operations in Canada, the United States, and Mexico.
- Experienced management team.
- Presence of established brands.
Haeufige Fragen zu OVATF
What are the key factors to evaluate for OVATF?
Ovation Science Inc. (OVATF) currently holds an AI score of 61/100, indicating moderate score. Key strength: Patented Invisicare drug delivery technology. Primary risk to monitor: Potential: Changing regulatory landscape could negatively impact operations.. This is not financial advice.
How frequently does OVATF data refresh on this page?
OVATF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven OVATF's recent stock price performance?
Recent price movement in Ovation Science Inc. (OVATF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Patented Invisicare drug delivery technology. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider OVATF overvalued or undervalued right now?
Determining whether Ovation Science Inc. (OVATF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying OVATF?
Before investing in Ovation Science Inc. (OVATF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding OVATF to a portfolio?
Potential reasons to consider Ovation Science Inc. (OVATF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Patented Invisicare drug delivery technology. Additionally: Established brands in key markets. The AI-driven MoonshotScore of 61/100 reflects solid quantitative fundamentals. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of OVATF?
Yes, most major brokerages offer fractional shares of Ovation Science Inc. (OVATF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track OVATF's earnings and financial reports?
Ovation Science Inc. (OVATF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for OVATF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is limited due to OTC status.
- AI analysis is pending.